Optas LLC’s Globus Medical GMED Stock Holding History

Optas LLC’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$228K	Sell	2,883 -271	-9%	-$23K	0.03%	404
2026 Q1	$272K	Buy	+3,154	New	+$283K	0.04%	341

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Optas LLC's GMED Position: Q2 2026 in Review

Optas LLC reduced its Globus Medical (GMED) stake by 8.6% in Q2 2026, selling an estimated $23K and leaving 2,883 shares worth $228K. The position accounts for 0.03% of the portfolio, ranked #404.

Optas LLC first reported a position in GMED in Q1 2026 and has held it in 2 quarters since. The position peaked at $272K in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Optas LLC held 2,883 shares of Globus Medical worth $228K as of Q2 2026.
Optas LLC sold 271 Globus Medical shares in Q2 2026, an estimated $23K.
Globus Medical made up 0.03% of Optas LLC's portfolio in Q2 2026, its #404 holding.
Optas LLC first reported a position in Globus Medical in Q1 2026 and has held it in 2 quarters since.
Optas LLC's Globus Medical position peaked at $272K in Q1 2026.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.